Shree Ganesh Remedies Ltd (SGRL) fair value: what the stock is really worth
As of Nov 18, 2026: fair value (intrinsic value) of Shree Ganesh Remedies Ltd stock ₹198, price ₹618, that is 68.0% below the price, quality 48 out of 100. Rating: strongly overvalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Shree Ganesh Remedies Ltd
SGRL · BSEFar too expensive (fair value 68% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 18, 2026.
How to read this chart
60‑month range ₹215.51 – ₹895.00 · fair‑value band ₹109.78 – ₹297.39 · the ₹617.90 price screens above the ₹198.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 18, 2026.
Every Wednesday you see whether Shree Ganesh Remedies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India.
Show moreShow less
It provides anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates.
The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including cyclopropanecarboxaldehyde, hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and various chemical applications.
In addition, it is involved in customized chemistry development and manufacturing; assets and infrastructure; and customized process of pharmaceutical chemicals. The company also exports its products. It serves various industries, including pharmaceuticals, biotechnology, medical devices, and others.
The company was incorporated in 1995 and is headquartered in Ankleshwar, India.
Stock analysis
Shree Ganesh Remedies Ltd (SGRL) currently trades at ₹617.90, while our model-based Fair Value estimate is ₹198.03, 68% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹308.09 per share, and 0 of the 24 models we run sit above the ₹617.90 price.
Bear case: the Asset-Based group reads lowest at ₹32.05, and 24 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹109.78 (bear) to ₹297.39 (bull), the price of ₹617.90 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Shree Ganesh Remedies Ltd reported revenue of ₹1.1B in FY2026 versus ₹713M in FY2022, a compound +11.3%/yr. Reported net income was ₹178M in FY2026, compounding +7.3%/yr from FY2022.
Key figures
Market cap ₹7.9B (≈ $84.9M) Micro · P/E ratio 51.4 · P/S ratio 8.01 · EPS (TTM) ₹12.02 · Net margin 15.6% · Return on equity 11.5% · Return on assets (EBIT) 16.4% (5-year average) · Operating margin 6.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (low confidence).
What moves the price
The share trades about 16% below its 52-week high and 54% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −68%, SGRL screens richer than that median.
Fair Value models
All 24 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
SGRL screens overvalued: fair value 68% below the price. Compare with Merck KGaA →
Compare Shree Ganesh Remedies Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 609 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $85.57 | $113.53 | +33% | vs SGRL |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥46.90 | ¥52.43 | +12% | vs SGRL |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,872 | ₹1,983 | +6% | vs SGRL |
| Haleon plc HLN | $9.08 | $8.47 | −7% | vs SGRL |
| Merck KGaA MRK | €149.50 | €108.83 | −27% | vs SGRL |
| Galderma Group GALD | CHF 187.55 | CHF 112.46 | −40% | vs SGRL |
| Takeda Pharmaceutical Company TAK | $21.27 | $11.23 | −47% | vs SGRL |
| Sandoz Group SDZ | CHF 81.50 | CHF 40.91 | −50% | vs SGRL |
| Teva Pharmaceutical Industries Limited TEVA | $42.23 | $20.74 | −51% | vs SGRL |
| Divi's Laboratories Limited DIVISLAB | ₹11,049 | ₹1,567 | −86% | vs SGRL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Shree Ganesh Remedies Ltd (SGRL) overvalued or undervalued?
What is the fair value of SGRL?
What is the quality score of SGRL?
What is the price target for Shree Ganesh Remedies Ltd (SGRL)?
What is the Shree Ganesh Remedies Ltd stock forecast for 2026?
What is the revenue of Shree Ganesh Remedies Ltd (SGRL)?
What growth is priced into Shree Ganesh Remedies Ltd (SGRL)?
What discount rate (WACC) does the fair value of SGRL use?
What is a reverse DCF?
How much growth has Shree Ganesh Remedies Ltd (SGRL) delivered so far?
How fast is the sector of Shree Ganesh Remedies Ltd (SGRL) growing?
What is the free cash flow yield of Shree Ganesh Remedies Ltd (SGRL)?
What is the intrinsic value of Shree Ganesh Remedies Ltd (SGRL)?
Is Shree Ganesh Remedies Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of SGRL?
How much is Shree Ganesh Remedies Ltd worth?
What do the bullish and bearish scenarios say about SGRL?
What is the P/E ratio of SGRL?
How solid is the balance sheet of Shree Ganesh Remedies Ltd (SGRL)?
How far is SGRL from its 52-week high?
Which stocks are comparable to Shree Ganesh Remedies Ltd?
Is Shree Ganesh Remedies Ltd stock attractive at the current price?
How is the fair value of SGRL calculated?
Is it still worth investing in stocks now?
What is the share price of Shree Ganesh Remedies Ltd (SGRL)?
What should I pay attention to with Shree Ganesh Remedies Ltd right now?
Key figures of Shree Ganesh Remedies Ltd
How large is the market capitalisation of Shree Ganesh Remedies Ltd (SGRL)?
What is the P/S ratio of Shree Ganesh Remedies Ltd (SGRL)?
What are the earnings per share of Shree Ganesh Remedies Ltd (SGRL)?
What is the net margin of Shree Ganesh Remedies Ltd (SGRL)?
What is the return on equity of Shree Ganesh Remedies Ltd (SGRL)?
What is the EBIT return on assets of Shree Ganesh Remedies Ltd (SGRL)?
What is the operating margin of Shree Ganesh Remedies Ltd (SGRL)?
How fast is revenue growing at Shree Ganesh Remedies Ltd (SGRL)?
How fast are earnings growing at Shree Ganesh Remedies Ltd (SGRL)?
How much net debt does Shree Ganesh Remedies Ltd (SGRL) carry?
Watch Shree Ganesh Remedies Ltd in the live analysis
One click puts Shree Ganesh Remedies Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.